Skip to main content
. 2022 Jul 4;13:3835. doi: 10.1038/s41467-022-31476-0

Fig. 7. UTX regulated lipid level through enzymatic activity of PHGDH in cultured renal cells.

Fig. 7

a, b TG level (a) and transcriptional levels of TG synthesis/lipid storage related genes (b) in UTX knockout or UTX/PHGDH double knockout (DKO) HK-2 cells, a n = 6, 6, 4, 4 biological samples for Ctrl + CT or Ctrl+PA or UTX KO + PA or DKO + PA group, respectively (mean ± SD); b n = 3 biological samples per group (mean ± SD). ***PTG (Ctrl+CT vs Ctrl+PA) < 0.0001, ***PTG (Ctrl+PA vs UTX KO+PA) < 0.0001, ***PTG (UTX KO+PA vs DKO+PA) < 0.0001; ***PMOGAT1 (Ctrl+CT vs Ctrl+PA) < 0.0001, ***PMOGAT1 (Ctrl+PA vs UTX KO+PA) < 0.0001, ***PMOGAT1 (UTX KO+PA vs DKO+PA) = 0.0006; ***PGPAM (Ctrl+CT vs Ctrl+PA) < 0.0001, ***PGPAM (Ctrl+PA vs UTX KO+PA) = 0.0002, ***PGPAM (UTX KO+PA vs DKO+PA) < 0.0001; ***PCIDEA (Ctrl+CT vs Ctrl+PA) < 0.0001, ***PCIDEA (Ctrl+PA vs UTX KO+PA) < 0.0001, ***PCIDEA (UTX KO+PA vs DKO+PA) < 0.0001; *PCIDEC (Ctrl+CT vs Ctrl+PA) = 0.0163, *PCIDEC (Ctrl+PA vs UTX KO+PA) = 0.014, **PCIDEC (UTX KO+PA vs DKO+PA) = 0.0014 (one-way ANOVA). c, d Cellular (c) and medium (d) serine (left) or glycine (right) level in UTX knockout or UTX/PHGDH double knockout HK-2 cells, n = 6 biological samples per group (mean ± SD). c *Pserine (Ctrl+CT vs Ctrl+PA) = 0.0109, **Pserine (UTX KO+PA vs DKO+PA) = 0.0039; **Pglycine (Ctrl+PA vs UTX KO+PA) = 0.0014; (d) *Pserine (Ctrl+PA vs UTX KO+PA) = 0.0299, *Pserine (UTX KO+PA vs DKO+PA) = 0.0415 (one-way ANOVA). e, f TG level (e) and transcriptional levels of TG synthesis/lipid storage related genes (f) in NCT-503 treated UTX knockout HK-2 cells, (e) n = 6, 6, 3, 3 biological samples for Ctrl+CT or Ctrl+PA or UTX KO + PA or UTX KO + NCT (L) + PA or UTX KO + NCT (H) + PA group, respectively (mean ± SD). ***PTG (Ctrl+CT vs Ctrl+PA) < 0.0001, ***PTG (Ctrl+PA vs UTX KO+PA) < 0.0001, **PTG (UTX KO+PA vs UTX KO+NCT (L)+PA) = 0.0023, **PTG (UTX KO+PA vs UTX KO+NCT (H)+PA) = 0.0023; (f) n = 3 biological samples per group (mean ± SD) ***PMOGAT1 (Ctrl+CT vs Ctrl+PA) = 0.0006, *PMOGAT1 (Ctrl+PA vs UTX KO+PA) = 0.0135, *PMOGAT1 (UTX KO+PA vs UTX KO+NCT (L)+PA) = 0.0348, ***PMOGAT1 (UTX KO+PA vs UTX KO+NCT (H)+PA) < 0.0001; ***PGPAM (Ctrl+CT vs Ctrl+PA) < 0.0001, ***PGPAM (Ctrl+PA vs UTX KO+PA) = 0.0001, ***PGPAM (UTX KO+PA vs UTX KO+NCT (L)+PA) < 0.0001, ***PGPAM (UTX KO+PA vs UTX KO+NCT (H)+PA) < 0.0001; **P CIDEA (Ctrl+CT vs Ctrl+PA) = 0.0049, **PCIDEA (Ctrl+PA vs UTX KO+PA) = 0.0073, *PCIDEA (UTX KO+PA vs UTX KO+NCT (L)+PA) = 0.0495, *PCIDEA (UTX KO+PA vs UTX KO+NCT (H)+PA) = 0.0470; ***PCIDEC (Ctrl+CT vs Ctrl+PA) = 0.0001, ***PCIDEC (Ctrl+PA vs UTX KO+PA) < 0.0001, **PCIDEC (UTX KO+PA vs UTX KO+NCT (L)+PA) = 0.0046, *PCIDEC (UTX KO+PA vs UTX KO+NCT (H)+PA) = 0.0243 (one-way ANOVA). g, h Cellular (g) and medium (h) serine (left) or glycine (right) level in NCT-503 treated UTX knockout HK-2 cells, n = 6 biological samples per group (mean ± SD). g ***Pserine (Ctrl+CT vs Ctrl+PA) < 0.0001, **Pserine (Ctrl+PA vs UTX KO+PA) = 0.001, **Pserine (UTX KO+PA vs UTX KO+NCT (L)+PA) = 0.005, **Pserine (UTX KO+PA vs UTX KO+NCT (H)+PA) = 0.002; ***Pglycine (Ctrl+CT vs Ctrl+PA) < 0.0001, ***Pglycine (Ctrl+PA vs UTX KO+PA) < 0.0001, ***Pglycine (UTX KO+PA vs UTX KO+NCT (L)+PA) < 0.0001, ***Pglycine (UTX KO+PA vs UTX KO+NCT (H)+PA) < 0.0001; (h) *Pserine (Ctrl+CT vs Ctrl+PA) = 0.0153, *Pserine (Ctrl+PA vs UTX KO+PA) = 0.021, **Pserine (UTX KO+PA vs UTX KO+NCT (L)+PA) = 0.009, ***Pserine (UTX KO+PA vs UTX KO+NCT (H)+PA) = 0.0005; *Pglycine (Ctrl+CT vs Ctrl+PA) = 0.0273, **Pglycine (Ctrl+PA vs UTX KO+PA) = 0.0022, *Pglycine (UTX KO+PA vs UTX KO+NCT (L)+PA) = 0.0188 (one-way ANOVA). ah At least three independent experiments were performed and similar results were obtained. Source data are provided in the Source Data file.